Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
A one-day meeting for local and regional healthcare specialists to discuss advances, problems, and solutions in various medical informatics venues in the New York area. The session will provide an opportunity to meet and talk to leading specialists who are at the forefront of HIT practice and innovation. This event is organized by Columbia University's Center for Advanced Information Management* and Department of Biomedical Informatics and is hosted by Pfizer Healthcare Informatics.
*The Center for Advanced Information Management at Columbia University is a NYSTAR-sponsored Center for Advanced Technology
WWW.CAT.CO LU M BIA.EDU
630 West 168th Street, PH 1501, New York, NY 10032 Telephone: 212 305 2944 Facsimile: 212 305 0196
Program Schedule
Time Event
8:30am 9:00am
Coffee, Pastries
Welcome and Introductions
Michael Cantor, MD, MA; Pfizer, Inc. Update Overview George Hripcsak, MD, MS; Columbia University Remarks on New York City Biomedical Technology Seth W. Pinsky NYC Economic Development Corporation Electronic Medical Records, Biobanks, and Personalized Medicine Erwin Bottinger, MD Where Are We With Implementing Health Information Exchange? Gilad Kuperman, MD, PhD BREAK An Update on the Primary Care Information Project and Population Health in NYC Jesse Singer, DO, MPH Evaluation of HIE Implementation: New Methods and Results from HEAL NY Phase 5 Jacqueline Merrill, RN, MPH, DNSc LUNCH Watsons Potential Impact on Medical Practice Part A: Herbert S. Chase, MD, MA Part B: Roberto Sicconi, Dr. Ing. Demo and Q/A Session Update on PACeR [Partnership to Advance Clinical Electronic Research] David A. Krusch, MD Looking to the Future: Biomedical Informatics Research, Training, and Practice Edward H. Shortliffe, MD, PhD Speaker/Attendee Mixer
9:15am
9:45am
10:15am 10:45am
11:15am
12:00pm 1:00pm
1:45pm
2:15pm
3:00pm
WWW.CAT.CO LU M BIA.EDU
630 West 168th Street, PH 1501, New York, NY 10032 Telephone: 212 305 2944 Facsimile: 212 305 0196
Erwin P. Bottinger, MD
Director, Charles R. Bronfman Institute for Personalized Medicine Professor, Nephrology and Professor, Pharmacology and Systems Therapeutics Mt. Sinai School of Medicine
Dr. Bottinger is a trained nephrologist and experimental biologist, and holds the Irene and Dr. Arthur Fishberg Professor of Medicine endowed chair at Mount Sinai School of Medicine since 2004. His research focuses on exploring and evaluating the translation of genetic and molecular information in medical practice. He is the Director of the Charles R. Bronfman Institute for Personalized Medicine at Mount Sinai and the principal architect of the Institutes Biobank since 2007. He served previously as Vice Chair for Research, Department of Medicine. In addition, Dr. Bottinger holds NIH-funded research grants in the area of mechanisms of kidney disease and diabetic complications. Dr. Bottinger was previously an Associate Professor of Medicine and Molecular Genetics at Albert Einstein College of Medicine in Bronx, New York, for six years. During his tenure at Albert Einstein he also held several hospital appointments, including Attending Physician in the Department of Medicine at Montefiore Medical Center and Jacobi Medical Center in the Bronx. Dr. Bottinger also served as Visiting Associate at the National Cancer Institute and Visiting Staff Physician in the Kidney Disease Section at the Warren Grant Magnuson Clinical Research Center of the National Institutes of Health in Bethesda, Maryland. Dr. Bottinger has published many scientific studies and has received several awards, including the Special Service Award from the National Cancer Institute and the Mellini Award for Excellence in Biomedical Sciences. In 2002, he was elected a member of the American Society for Clinical Investigation. Trained in Europe, Dr. Bottinger received his medical degree from Friedrich-Alexander Universitat School of Medicine in Erlangen, Germany. He moved to New York to pursue a residency in internal medicine at Cabrini Medical Center and later completed a clinical and research fellowship in nephrology at Massachusetts General Hospital and Harvard Medical School in Boston. In addition, he served as a research fellow at the National Cancer Institute, where he stayed on as a Visiting Associate for four more years. Dr. Bottinger joined Mount Sinai in 2004.
WWW.CAT.CO LU M BIA.EDU
630 West 168th Street, PH 1501, New York, NY 10032 Telephone: 212 305 2944 Facsimile: 212 305 0196
He is the Principle Investigator on a $3.7 million grant, funded through the Office of the National Coordinator, for UniversityBased Training of Health Information Technology Professionals. He is also a medical advisor to the IBM team developing the medical version of Watson. He continues to develop new medical educational programs at Columbia where he is now implementing a four-year curriculum in medical decision-making and a capstone course in Biomedical Informatics.
David A. Krusch, MD
Director - Department of Medical Informatics Professor - Department of Surgery, Oncology and Professor Department of Medical Informatics University of Rochester Medical Center
Dave received his M.D. from the Johns Hopkins School of Medicine and then completed his residency and fellowship in surgery at the University of Virginia. His areas of specialty interest include gastrointestinal surgery, minimally invasive upper abdominal surgery, vascular access and surgical treatment of hematological diseases. Dr. Krusch is also the Director of the Department of Medical Informatics and the Chief Medical Information Officer. He has received several awards and honors, including the University of Rochester Medical Center Board Award for Excellence, 2003; Buswell Fellowship Award, University of Rochester School of Medicine and Dentistry University of Rochester School of Medicine and Dentistry, 1993; The Bigger-Lehman Award, Virginia Surgical Society Virginia Surgical Society.
WWW.CAT.CO LU M BIA.EDU
630 West 168th Street, PH 1501, New York, NY 10032 Telephone: 212 305 2944 Facsimile: 212 305 0196
Jesse is board certified in Public Health and Preventive Medicine. He joined PCIP in 2007 as the Director of Quality Informatics and in 2009 became PCIP's Executive Director of Development. He was responsible for overseeing the collaborations between health information technology vendors and PCIP to incorporate public health priorities and functions into these products. Such functions include quality measurement and population health surveillance, clinical decision support, health information exchange and interfaces with public health agencies. Dr. Singer is a frequent presenter and panelist, focusing on health information technology (HIT) as a means to improve public health. He conceptualized and led the development of the Hub, an innovative model for improving public health through a system integrated with EHRs, allowing rapid deployment of public health queries, a clinical decision support system, and secure provider communication. This system currently covers close to 2 million patients in NYC. PCIP received the 2011 HIMSS Public Health Davies Award of Excellence for its positive impact on population health through HIT innovations such as the Hub.
continued >
WWW.CAT.CO LU M BIA.EDU
630 West 168th Street, PH 1501, New York, NY 10032 Telephone: 212 305 2944 Facsimile: 212 305 0196
In 1983, New York State established a Center for Advanced Technology (CAT) Program to promote the collaboration between its industry base and its major research institutions. The goal was to facilitate technology transfer and commercialization using the expertise and resources in academia to benefit companies economically. Currently, the program continues with 15 CATs at 13 institutions located around the state. Each CAT has a specific technology focus (http://www.nystar.state.ny.us/cats.htm) and approach to helping its partner companies. The CAT program is supported by Empire State Development, Division of Science, Technology and Innovation (a.k.a. NYSTAR). NYSTAR currently offers a range of programs to help promote the states technology base. Columbia Universitys Center for Advanced Information Management has been a participant in the CAT program since its inception. CAIMs focus is at the intersection of biomedical science, information technology, and biomedical imaging, with the occasional inclusion of other areas of biomedicine and information processing. Its main contributing units are the Department of Biomedical Informatics and the Center for Computational Biology and Bioinformatics, both at the medical center (College of Physicians and Surgeons), and the Computer Science Department and imaging group of the Department of Biomedical Engineering, both in the School of Engineering and Applied Science. This broad range of expertise serves CAIM well in allowing for innovative interdisciplinary projects involving specialists from both schools and campuses.
www.dbmi.columbia.edu
The Columbia University Department of Biomedical Informatics is among the oldest in the nation. Its goals are to discover new information methods, to augment the biomedical knowledge base, and to improve the health of the population. DBMIs 30 faculty members and 60 students work in a highly collaborative environment, applying informatics from the atomic level to global populations. Areas of application include: CLINICAL CARE. Design clinical information systems and mine the electronic health record. BIOLOGY. Includes systems biology, structural biology, and virology, on studies in partnership with the Center for Computational Biology and Bioinformatics. PUBLIC HEALTH. Design systems to promote and protect the health of communities, improve public health systems, and deploy information technology internationally. TRANSLATIONAL RESEARCH. Integrate biological and clinical knowledge and facilitate multidisciplinary science.
Pfizer Incorporated
Pfizer applies science and its global resources to improve health and well-being at every stage of life. It strives to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Pfizers diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world's best-known consumer products. Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with its responsibility as the world's leading biopharmaceutical company, Pfizer also collaborates with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on it. To learn more, please visit www.pfizer.com. Pfizer has co-sponsored the medical informatics update since its inception.